Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feinberg

Showing results (121-130 of 161) with videos related to

Pageof 17
Sort By:
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|June 5, 2024
Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use DrugsBeth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Journal of Medical Internet Research|June 2, 2023
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and ExperiencesAlison Karasz, Krupa Merchant, Julia Arnsten, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Medical Care|January 10, 2025
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use DrugsThomas J Stopka, Bridget M Whitney, David de Gijsel, et al.
Pageof 17

Showing results (121-130 of 161) with videos related to

Sort By:
Pageof 17
Viruses|October 26, 2024
Variability of Hepatitis C Treatment Cascade Outcomes among People Who Inject Drugs across Geographically Diverse Clinics in the US: The HERO StudySnehal S Lopes, Moonseong Heo, Irene Pericot-Valverde, et al.
The International Journal on Drug Policy|December 16, 2023
Self-reported and measured adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs: The HERO studySnehal S Lopes, Irene Pericot-Valverde, Julia Arnsten, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|June 5, 2024
Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use DrugsBeth Prusaczyk, Sandra Tilmon, Joshua Landman, et al.
Journal of Medical Internet Research|June 2, 2023
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and ExperiencesAlison Karasz, Krupa Merchant, Julia Arnsten, et al.
The Journal of Infectious Diseases|September 16, 2011
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final resultsPaul E Sax, Camlin Tierney, Ann C Collier, et al.
Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.
Open Forum Infectious Diseases|November 29, 2023
Reduction in Depressive Symptoms in People who Inject Drugs who Are Cured of Hepatitis C Virus Infection: The HERO StudyIrene Pericot-Valverde, Snehal S Lopes, Shadi Nahvi, et al.
BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.
Journal of Psychosomatic Research|October 22, 2025
Depression profiles and hepatitis C treatment outcomes among people who inject drugs: The HERO studyIrene Pericot-Valverde, Snehal S Lopes, Jessica Obeysekare, et al.
Medical Care|January 10, 2025
Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use DrugsThomas J Stopka, Bridget M Whitney, David de Gijsel, et al.
Pageof 17